This report contains market size and forecasts of Nintedanib in global, including the following market information:
Global Nintedanib Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Nintedanib Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Nintedanib companies in 2021 (%)
The global Nintedanib market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
100mg*10 Capsules Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Nintedanib include Boehringer Ingelheim Pharma. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Nintedanib manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nintedanib Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Nintedanib Market Segment Percentages, by Type, 2021 (%)
100mg*10 Capsules
150mg*10 Capsules
100mg*30 Capsules
150mg*30 Capsules
150mg*60 Capsules
Global Nintedanib Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Nintedanib Market Segment Percentages, by Application, 2021 (%)
Locally Advanced NSCLC
Variant NSCLC
Locally Recurrent NSCLC
Global Nintedanib Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Nintedanib Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nintedanib revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Nintedanib revenues share in global market, 2021 (%)
Key companies Nintedanib sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Nintedanib sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Boehringer Ingelheim Pharma